Utility of the midbrain tegmentum diameter in the diferential diagnosis of progressive supranuclear palsy from idiopathic Parkinson’s disease

Journal of Clinical Neurology (Korea)

Volumn 11, Issue 3, 2015, Pages 268-274

  Kim, Yool Hee ^a   Ma, Hyeo Il ^a   Kim, Yun Joong ^a,b,c  

^a Hallym University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Hallym University Medical Center   (South Korea)

Author keywords

Idiopathic Parkinson s Disease; Mri; Neuroimaging; Progressive supranuclear palsy

Indexed keywords

EID: 84937034260     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2015.11.3.268     Document Type: Article

References (15)

1. Litvan I, Bhatia K P, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-486.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
3. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001;58:1076-1079.
4. Righini A, Antonini A, Ferrarini M, de Notaris R, Canesi M, Triulzi F, et al. Tin section MR study of the basal ganglia in the diferential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr 2002;26:266-271.
5. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003;210:57-60.
6. Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005;64:2050-2055.
7. Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, et al. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007;116:37-42.
8. Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al. MR imaging index for diferentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246:214-221.
9. Sung YH, Park KH, Lee YB, Park HM, Shin DJ, Park JS, et al. Mid-brain atrophy in subcortical ischemic vascular dementia. J Neurol 2009;256:1997-2002.
10. Longoni G, Agosta F, Kostić VS, Stojković T, Pagani E, Stošić-Opinćal T, et al. MRI measurements of brainstem structures in patients with Richardson’s syndrome, progressive supranuclear palsy-parkinson-ism, and Parkinson’s disease. Mov Disord 2011;26:247-255.
11. Morelli M, Arabia G, Salsone M, Novellino F, Giofrè L, Paletta R, et al. Accuracy of magnetic resonance parkinsonism index for diferen-tiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord 2011;3:527-533.
12. Morelli M, Arabia G, Messina D, Vescio B, Salsone M, Chiriaco C, et al. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson’s disease. Mov Disord 2014;29:488-495.
13. Righini A, Antonini A, De Notaris R, Bianchini E, Meucci N, Sacilot-to G, et al. MR imaging of the superior profle of the midbrain: difer-ential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 2004;25:927-932.
14. Massey LA, Jäger HR, Paviour DC, O’Sullivan SS, Ling H, Williams DR, et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013;80:1856-1861.
15. Whitwell JL, Jack CR, Parisi JE, Gunter JL, Weigand SD, Boeve BF, et al. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol 2013;20:1417-1422.